Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Appendicitis Market Share

ID: MRFR//3849-CR | 125 Pages | Author: Rahul Gotadki| August 2019

Healthcare spending worldwide is going up, and in the last few decades, regions like the Americas and Europe have seen an increase in healthcare costs. In 2015, the US spent a lot on healthcare – about 5.8% more than before, reaching a whopping USD 3.2 trillion. The following year, North America, including Canada, also spent more on healthcare. Canada, in particular, felt the pressure because of more older people needing healthcare. In 2016, the US economy grew by 1.6%, but changes in rules about research and development (R&D) spending happened in 2017. In 2016, the US spent around 527.5 billion on research and development. Health insurance coverage increased because of a law called the Affordable Care Act in 2010, leading to even more spending on healthcare. Additionally, in 2016, healthcare organizations were no longer required to pay a special tax on medical devices, which was part of the Medical Device Excise Tax Act from 2013.

In the UK and Germany, spending on healthcare also went up, but not as much. Western Europe, which includes countries like Germany and the UK, felt the need to save money on healthcare because the economy wasn't growing as much, and there was a lot of economic pressure. In 2014, Germany spent about EUR 321 billion on healthcare, making it the highest spender in Europe. France spent the second-highest, around EUR 237 billion, followed by the UK at EUR 223 billion in the same year. In 2014, Germany, Slovakia, and the Netherlands spent a lot on mandatory healthcare programs and required medical savings. Europe, as a whole, also increased its spending on research and development, with a strong push from the government. In 2017, Europe made up about 20.8% of the total global spending on research and development.

Around the world, the amount of money spent on healthcare is going up. Over the last few decades, places like the Americas and Europe have seen a rise in how much they spend on healthcare. In 2015, the US spent a lot – about 5.8% more than before, reaching a massive USD 3.2 trillion. The next year, North America, including Canada, also spent more on healthcare. Canada felt the pressure because more older people needed healthcare. In 2016, the US economy grew by 1.6%, but there were changes in rules about research and development (R&D) spending in 2017. In 2016, the US spent around 527.5 billion on research and development. More people getting health insurance because of a law called the Affordable Care Act in 2010 led to even more spending on healthcare. Also, in 2016, healthcare organizations didn't have to pay a special tax on medical devices anymore, a rule from the Medical Device Excise Tax Act in 2013.

Covered Aspects:

Report Attribute/Metric Details
Base Year For Estimation 2022
Historical Data 2018- 2022
Forecast Period 2023-2032
Growth Rate 4.10% (2023-2032)

Global Appendicitis Market Overview

Appendicitis Market Size was valued at USD 7.1 Billion in 2022. The Appendicitis market industry is projected to grow from USD 7.39 Billion in 2023 to USD 10.19 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.10% during the forecast period (2023 - 2032). Appendicitis cases are rising, and illness awareness is rising are the key market drivers enhancing the market growth.Appendicitis Market Overview

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Appendicitis Market Trends

  • Growing awareness is driving the market growth

Market CAGR for appendicitis is being driven by the rising awareness among people. With a mean age of 28, appendicitis mostly affects people between the ages of 5 and 45. Accordingly, the incidence is roughly 233/100,000 persons. Compared to chronic appendicitis, acute appendicitis is more common. Acute appendicitis affects one in every fifteen persons at some point. In the United States, appendectomies are performed more than 250,000 times annually, yet people that consume a high-fiber diet have a reduced incidence of the procedure. The combined incidence of appendicitis or appendectomy worldwide is approximately 100 per 100,000 person-years. Children with cystic fibrosis may develop pediatric appendicitis, which has a higher risk. A family history of the disease may also increase a child's chance of developing appendicitis. The minimally invasive Transumbilical Laparoscopic Assisted Appendicectomy procedure can be used to diagnose it. Although it has not yet become the gold standard, laparoscopic-assisted single-port appendectomy (SPA) has been done on children and has been deemed safe. Imaging is helpful in uncertain circumstances, such as female patients of childbearing age, as appendicitis is thought to be a clinical diagnosis in these situations. Many pieces of equipment are used to diagnose appendicitis, such as ultrasound, which is becoming popular, especially in children who are most at risk from ionizing radiation. The benefits include lower costs than other imaging techniques and no exposure to ionizing radiation. C.T. of the abdomen and pelvis is also regarded as the preferred modality for final assessing patients who have been screened for potential appendicitis. The  market for appendicitis diagnostics and treatment will grow as appendicitis cases rise.

The high  prevalence of appendicitis is a key factor driving the market. Although appendicitis is a common ailment worldwide and more common in wealthy economies, it is becoming more common in emerging nations. Due to their diets' inclusion of dietary fibers, which reduces the incidence of appendicitis, African countries have less acute appendicitis. The rising prevalence of pediatric appendicitis is a significant driver of the appendicitis industry.

Other factors boosting the growth of the appendicitis market ly include awareness and quicker adoption of diagnostic procedures for the condition. Compared to emerging economies, these approaches are more prevalent in established economies like the U.S. and Europe. However, increasing knowledge of the many appendicitis diagnostic tests is anticipated to promote their use in developing nations in Asia and Latin America. Another element fueling the need for surgery for the appendix issue is minimally invasive procedures. The diagnosis of appendicitis using blood biomarkers has yielded promising results. Thus, driving the Appendicitis market revenue.

Appendicitis Market Segment Insights

Appendicitis Type Insights

The  Appendicitis market segmentation, based on type, includes acute and chronic. The acute segment dominated the market, accounting for 68% of market revenue. Acute appendicitis is a common surgical emergency diagnosed by combining a clinical picture with the history, examination, and investigations. Acute appendicitis has typically been treated with an appendectomy. There are numerous described diagnostic scoring systems for acute appendicitis.

Appendicitis Diagnosis & Treatment Insights

The  Appendicitis market segmentation, based on diagnosis & treatment, includes diagnosis {ultra sound imaging, Ct Scan, others}, treatment {medication, surgery, others}). The treatment segment dominated the market. Surgery to remove the inflamed appendix is typically part of the therapy for appendicitis. The procedure used to remove the appendix is called an appendectomy. It is the accepted course of action for practically all appendicitis patients. One of the following techniques, such as laparoscopic surgery or a laparotomy, is used to operate. In laparoscopic surgery, the appendix is removed using a series of tiny incisions and specialized surgical equipment fed via the incisions. Laparoscopic surgery has a quicker recovery period and causes fewer complications, such as infections acquired in the hospital. While a laparotomy only requires a single incision in the lower right corner of your belly to remove the appendix. Surgery, including laparoscopy, is most frequently chosen for less invasive treatments.

Appendicitis End User Insights

The  Appendicitis market segmentation, based on end users, includes hospitals & clinics, and diagnostic centers. The diagnostic centers generated the most income (70.4%). Tests are required to confirm the diagnosis and rule out other illnesses if the symptoms of appendicitis are not typical. The diagnosis of appendicitis can now be made using a variety of diagnostic procedures. An imaging test is the best way to determine whether you have appendicitis or another type of abdominal pain. To create an image of the anatomy of your organs during an abdominal ultrasound, the doctor uses a transducer to bounce safe, painless sound waves off of your organs. A radiologist examines the images and may reveal indications of an appendiceal lumen obstruction, an appendix rupture, inflammation, or other causes of stomach pain.

Figure 1  Appendicitis Market, by End User, 2022 & 2032 (USD Billion)Appendicitis Market, by End User, 2022 & 2032

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Appendicitis Regional Insights

By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North American Appendicitis market area will dominate this market because there is a greater need for good treatment as appendicitis is becoming more common, more people are aware of it, and it is more common. The US spends more on healthcare than in previous years, which could cause the medical device business to grow more quickly.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.


Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe's Appendicitis market accounts for the second-largest market share. The region's appendicitis market is expanding due to ongoing research in molecular diagnostic technologies and the increased occurrence of infectious diseases. Further, the German Appendicitis market held the largest market share, and the UK Appendicitis market was the fastest-growing market in the European region.

The Asia-Pacific Appendicitis Market is expected to grow at the fastest CAGR from 2023 to 2032 due to the rise in outpatient venues offering imaging services and their focus on forming partnerships to improve imaging services and patient care. Moreover, China's Appendicitis market held the largest market share, and the Indian Appendicitis market was the fastest-growing market in the Asia-Pacific region.

Appendicitis Key Market Players & Competitive Insights

Leading industry companies are making significant R&D investments to diversify their product offerings, which will drive the Appendicitis market's expansion. Important market developments include new product releases, contractual agreements, mergers and acquisitions, greater investments, and collaboration with other organizations. Market participants also engage in several strategic actions to increase their worldwide presence. The Appendicitis industry must provide affordable products to grow and thrive in a more competitive and challenging market environment.

Local manufacturing to cut operating costs is one of the key business tactics manufacturers use in the  Appendicitis industry to help clients and expand the market sector. The Appendicitis industry has offered some of the most significant advantages in recent years. Major players in the Appendicitis market, including B. Braun, and others, are attempting to increase market demand by investing in research and development operations.

  • Braun is one of the top producers and suppliers of healthcare products worldwide. Every service that B. Braun offers draws on all of our knowledge and expertise and the company's significant experience and deep understanding of user demands spanning more than 180 years. B. Braun works to safeguard and enhance people's health with its ever-expanding line of suitable medical care products. Five thousand different products make up the B. Braun product line, 95% of which are made by the business. Additionally, B. Braun is a system provider that works closely with its clients to produce the optimum solution for patients, significantly advancing medical science. This is done by providing supplemental services and consultation.
  • An American manufacturer of medical equipment is Medtronic plc. Due to its 2015 acquisition of the Irish-based Covidien, the business has its operational and executive offices in Minneapolis, Minnesota, and its legal headquarters in Ireland. Although it works largely in the United States, it also does so in more than 150 other nations. The Diabetes Group, the Restorative Therapies Group, the Cardiac and Vascular Group, and the Minimally Invasive Therapies Group are Medtronic's four primary business divisions. More than 30 chronic diseases, including Parkinson's disease,  spinal abnormalities, heart failure, urine incontinence, obesity, Down syndrome, chronic pain, and diabetes, are treated by the devices and therapies that Medtronic develops and produces.

    Key Companies in the Appendicitis market include

    • Johnson & Johnson Services Inc (US)

    • Pfizer Inc (US)

    • Lupin (India)

    • Siemens (Germany)

    • Koninklijke Philips NV (Netherlands)

    • Becton, Dickinson and Company (US)

    • Braun Melsungen AG (Germany)

    • Cook (US)

    • Medtronic (Ireland)

    • Teva Pharmaceutical Industries Ltd (Israel).

    Appendicitis Industry Developments

    October 2020 With a focus on veterans, minorities, and other underrepresented areas, B. Braun Medical Inc. (B. Braun) and Kerma Medical Products, Inc. (Kerma) announced a collaboration to improve the development and delivery of healthcare products and services. The businesses will collaborate on various projects, such as product development, co-marketing chances, strategic sourcing, sustainable manufacturing, and diversity initiatives.

    Appendicitis Market Segmentation

    Appendicitis Type Outlook

    Appendicitis Diagnosis & Treatment Outlook

    • Diagnosis

    • Ultra Sound Imaging

    • Ct Scan

    • Others

    • Treatment

    • Medication

    • Surgery

    • Others

    Appendicitis End User Outlook

    • Hospitals & Clinics

    • Diagnostic Centers

    Appendicitis Regional Outlook

    • North America

      • US

      • Canada

    • Europe

      • Germany

      • France

      • UK

      • Italy

      • Spain

      • Rest of Europe

    • Asia-Pacific

      • China

      • Japan

      • India

      • Australia

      • South Korea

      • Australia

      • Rest of Asia-Pacific

    • Rest of the World

      • Middle East

      • Africa

      • Latin America

    Leading companies partner with us for data-driven Insights
    client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
    Kindly complete the form below to receive a free sample of this Report
    Please fill in Business Email for Quick Response

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Purchase Option
    Single User $ 4,950
    Multiuser License $ 5,950
    Enterprise User $ 7,250
    Compare Licenses
    Tailored for You
    • Dedicated Research on any specifics segment or region.
    • Focused Research on specific players in the market.
    • Custom Report based only on your requirements.
    • Flexibility to add or subtract any chapter in the study.
    • Historic data from 2014 and forecasts outlook till 2040.
    • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
    • Provide cross segmentation in applicable scenario/markets.